Implication of Malignancy and Prognosis of p27kip1, Cyclin E, and Cdk2 Expression in Epithelial Ovarian Tumors

Abstract

Objective. The aim of this study was to further evaluate whether the expression of p27kip1, cyclin E, and cdk2 is related to the malignancy of ovarian tumors and whether their expressions, alone or in combination, are associated with prognosis in epithelial ovarian carcinoma.Methods. Immunohistochemical analysis using anti-p27kip1, anti-cyclinE, and anti-cdk2 antibodies was carried out for 103 cases consisting of benign, borderline, and malignant ovarian tumors, and Western blot analysis and cdk2 activity assay were performed in 26 fresh ovarian tumor samples.Results. p27kip1 expression was reduced in ovarian carcinomas in contrast to benign and borderline tumors. The expression of cyclin E and cdk2 gradually increased from benign to borderline to malignant tumors. Kaplan–Meier survival analysis showed that patients with p27kip1 expression had a high overall survival rate. Patients with cyclin E overexpression had a low overall survival rate. When the combination of these proteins was analyzed, patients with the p27kip1 (−)/cyclin E (++)/cdk2 (++) phenotype were significantly associated with the poorest overall survival. In multivariate Cox regression analysis, the combined phenotype of p27kip1 (−)/cyclin E (++)/cdk2 (++) was independently related to poor prognosis.Conclusions. Our results suggest that loss of p27kip1 expression and overexpression of cyclin E or cdk2 were significantly associated with malignancy in ovarian tumors. p27kip1 and cyclin E proteins may be valuable prognostic factors for epithelial ovarian carcinoma patients. Furthermore, the combined evaluation of p27kip1/cyclin E/cdk2 may provide the most important prognostic implication.